Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2016; 6(12): 032-041


Synthesis of aliphatic biodegradable polyesters nanoparticles as drug carrier for cancer treatment

Yasser Assem, Fahima M Helaly, AbdelMohsen Soliman, Sherein Abdelmoez.




Abstract

New amphiphilic triblock copolymers of poly(hexylene adipates) (PHA) and poly(ethylene glycol) (mPEG) having different hydrophobic/hydrophilic ratios were synthesized using a facile one-pot condensation reaction. Three samples of three different molecular weights were synthesized and characterized using different techniques. The synthesized copolymers were exploited to prepare core-shell nanoparticles with hydrophobic PHA and hydrophilic mPEG forming the core and shell, respectively. The drug loading efficiency and drug release properties of the mPEG-PHA-mPEG nanoparticles were investigated using 5-fluorouracil (5-FU) as a drug model. The drug loading efficacy of the nanoparticles was found to be dependent upon the polymer hydrophobicity. Drug release characteristics also depended on polymer hydrophobicity. The cytotoxicity of released 5-FU was monitoring as an antiproliferative agent against human liver cancer cell line (HEPG2) as well as antimicrobial against both gram positive and gram negative bacteria. Results of the in vitro cytotoxic activity of the released 5-FU showed a sustained antiproliferative potency against the tested human liver cancer cell line for 26 days. Besides, results of the antimicrobial study revealed that the most potent inhibitory activity was against S. aureus which shows hindrance zone of about 48 mm against the tested reference strain.

Key words: Block copolymers; nanoparticles; drug delivery; polyester; controlled release; antitumor drugs






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.